Segmed Secures $10.4 Million Series A Funding, Led by iGan Partners and Advocate HealthThe investment is a pivotal milestone allowing Segmed to further expand its medical imaging solutions for artificial intelligence development and real-world evidencePALO ALTO, Calif., September 3, 2024-- Segmed, Inc., a leader in providing real-world imaging data for health innovation, has raised a $10.4 million Series A funding round.

Segmed获得了由iGan合作伙伴和倡导健康组织牵头的1040万美元的A系列资金。该投资是一个关键的里程碑，使Segmed能够进一步扩展其用于人工智能开发和现实世界证据的医学成像解决方案。加利福尼亚州阿尔托，2024年9月3日——Segmed，Inc.，一家为健康创新提供现实世界成像数据的领导者，已经筹集了1040万美元的A系列资金。

The oversubscribed round was led by iGan Partners and Advocate Health, with participation from Castellan Group, Engine Health Capital, Bold Brain Ventures, Fox Chase Cancer Center, and current investors including Y Combinator, Nina Capital, Nova Capital, Blumberg Capital, and Expeditions Fund. The current Series A round follows a financing by Flashpoint Growth Debt Fund received in 2023..

超额认购的一轮由iGan合作伙伴和倡导健康组织牵头，Castellan Group、Engine Health Capital、Bold Brain Ventures、Fox Chase Cancer Center以及包括Y Combinator、Nina Capital、Nova Capital、Blumberg Capital和Expeditions Fund在内的现有投资者参与。目前的A轮融资是在2023年收到Flashpoint增长债务基金融资之后进行的。。

Since Segmed's inception, it has been committed to unlocking diverse cohorts of imaging data to support AI development and further clinical research. We are excited to announce the next step in that journey. Segmed will use the new funding to further expand its footprint in the healthcare AI space as well as to bring medical imaging to the biopharmaceutical and life science world.

自Segmed成立以来，它一直致力于解锁不同的成像数据队列，以支持AI开发和进一步的临床研究。我们很高兴宣布这一旅程的下一步。Segmed将利用新资金进一步扩大其在医疗保健AI领域的足迹，并将医学成像带入生物制药和生命科学领域。

Our data network of leading healthcare providers enables innovators to get access to heterogeneous and diverse de-identified imaging data that can be linked with other data types. Additionally, our technology allows clients to access, de-identify, standardize, and build cohorts of medical imaging data within their own environment..

我们由领先的医疗保健提供商组成的数据网络使创新者能够访问可以与其他数据类型链接的异构和多样化的去识别成像数据。此外，我们的技术允许客户在自己的环境中访问、取消识别、标准化和构建医疗成像数据队列。。

'We are excited to partner with such a select group of health systems and healthcare technology investors to support Segmed as they continue to disrupt the healthcare industry with their innovative approach to real-world imaging data. Segmed's platform has the potential to drive significant improvements in patient care and healthcare outcomes, and iGan stands ready to continue to support their dynamic growth and the significant impact they are poised to make on healthcare technology going forward,' said Sam Ifergan, managing partner at iGan Partners..

“我们很高兴能与这样一群精选的医疗系统和医疗保健技术投资者合作，支持Segmed，因为他们继续以创新的方法处理现实世界的成像数据，扰乱医疗保健行业。“Segmed的平台有可能推动患者护理和医疗保健结果的显着改善，iGan随时准备继续支持其动态增长以及他们准备对未来医疗保健技术产生的重大影响，”iGan Partners的管理合伙人萨姆·伊夫根（Sam Ifergan）说。。

'Advocate Health is an industry leader in utilizing innovation to serve the health needs of individuals, families and communities,' said Emilie McKenna, managing director of strategic development and investment at Advocate Health. 'We're driven to advance the science of medicine. To that end, our team is dedicated to developing the most comprehensive provider-based research data set in the country.

Advocate Health战略发展和投资董事总经理埃米莉·麦肯纳（EmilieMkenna）说，“Advocate Health是利用创新满足个人、家庭和社区健康需求的行业领导者。”我们被驱使去推进医学科学。为此，我们的团队致力于开发国内最全面的基于提供商的研究数据集。

We look forward to supporting Segmed in the shared goal of unlocking imaging data to accelerate medical research.'.

我们期待着支持Segmed实现解锁成像数据以加速医学研究的共同目标。”。

'We founded Segmed five years ago to improve patient outcomes by revolutionizing medical imaging research,' said Martin Willemink, CEO and co-founder at Segmed. 'We are thrilled to have the continued support from investors like iGan Partners and Y Combinator, as well as the addition of clinical powerhouses like Advocate Health and Fox Chase Cancer Center.

Segmed首席执行官兼联合创始人马丁·威勒米克（MartinWillemink）说：“我们五年前成立了Segmed，通过彻底改变医学影像研究来改善患者的预后。”我们很高兴能得到iGan Partners和Y Combinator等投资者的持续支持，以及Advocate Health和Fox Chase癌症中心等临床巨头的加入。

Their expertise and experience will be invaluable as we continue to develop cutting-edge solutions for the future..

随着我们继续为未来开发尖端解决方案，他们的专业知识和经验将是无价的。。

'Segmed deeply appreciates the support and confidence demonstrated by these significant investments and strategic partnerships to reshape the landscape of medical imaging utilization, ultimately advancing health care,' he said.

他说：“Segmed非常感谢这些重大投资和战略伙伴关系所显示的支持和信心，以重塑医学影像利用的格局，最终推进医疗保健。”。

About Segmed, Inc.

关于Segmed，Inc。

Segmed, Inc. collaborates with life-sciences, health care and technology firms to streamline access to medical imaging studies for advancing biopharmaceutical R&D, AI development and enhancing global health care initiatives. Segmed acquires, de-identifies, standardizes and subsequently provides medical imaging data to researchers and innovators in AI/ML and Real-World Imaging Data (RWiD) through its proprietary data platform.

Segmed，Inc.与生命科学、医疗保健和技术公司合作，简化医学成像研究的获取，以推进生物制药研发、人工智能开发和增强全球医疗保健计划。Segmed通过其专有数据平台，收购、取消识别、标准化并随后向AI/ML和真实世界成像数据（RWiD）的研究人员和创新者提供医学成像数据。

Before Segmed, acquiring imaging data for medical research was a time-consuming process that could take months, or even years. By partnering with thousands of health care locations and imaging clinics across five continents, researchers and AI developers can access the studies they need..

在Segmed之前，获取医学研究的成像数据是一个耗时的过程，可能需要几个月甚至几年。通过与五大洲数千家医疗保健机构和成像诊所合作，研究人员和人工智能开发人员可以获得他们需要的研究。。

For more information about Segmed, visit www.segmed.ai or follow us on LinkedIn @segmed-ai.Contact:

有关Segmed的更多信息，请访问www.Segmed.ai或通过LinkedIn@Segmed-ai关注我们。联系方式：

Media Contact

媒体联系人

press@segmed.ai

press@segmed.ai